Varun Khurana, Ph.D.
Affiliations: | 2014 | Pharmaceutical Science | University of Missouri - Kansas City, USA |
Area:
PharmacyGoogle:
"Varun Khurana"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Ashim K. Mitra | grad student | 2014 | University of Missouri - Kansas City | |
| (Role of membrane transporters in drug delivery, drug disposition and drug-drug interactions.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mandal A, Cholkar K, Khurana V, et al. (2017) Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery. Molecular Pharmaceutics |
| Mandal A, Agrahari V, Khurana V, et al. (2016) Transporter effects on cell permeability in drug delivery. Expert Opinion On Drug Delivery |
| Mitra AK, Agrahari V, Mandal A, et al. (2015) Novel delivery approaches for cancer therapeutics. Journal of Controlled Release : Official Journal of the Controlled Release Society |
| Vaishya R, Khurana V, Patel S, et al. (2015) Long-term delivery of protein therapeutics. Expert Opinion On Drug Delivery. 12: 415-40 |
| Khurana V, Vadlapudi AD, Vadlapatla RK, et al. (2015) Functional characterization and molecular identification of vitamin C transporter (SVCT2) in human corneal epithelial (HCEC) and retinal pigment epithelial (D407) cells. Current Eye Research. 40: 457-69 |
| Khurana V, Kwatra D, Pal D, et al. (2014) Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells. International Journal of Pharmaceutics. 474: 14-24 |
| Vaishya RD, Khurana V, Patel S, et al. (2014) Controlled ocular drug delivery with nanomicelles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 422-37 |
| Khurana V, Minocha M, Pal D, et al. (2014) Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 249-59 |
| Khurana V, Minocha M, Pal D, et al. (2014) Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 179-90 |
| Kwatra D, Vadlapudi AD, Vadlapatla RK, et al. (2014) Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters. Drug Metabolism and Drug Interactions. 29: 101-10 |